Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

BIOGB:SS

290.500 SEK 10.500 3.75%

As of 11:30:00 ET on 05/22/2015.

Snapshot for BioGaia AB (BIOGB)

Open: 280.000 Day's Range: 279.000 - 292.000 Volume: 24,381
Previous Close: 280.000 52wk Range: 150.104 - 292.000 1-Yr Rtn: +49.45%

Stock Chart for BIOGB

No chart data available.
  • BIOGB:SS 290.500
  • 1D
  • 1M
  • 1Y
280.000
Interactive BIOGB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIOGB

Current P/E Ratio (ttm) 53.6671
Estimated P/E(12/2015) 35.8200
Relative P/E vs. OMX 3.2699
Earnings Per Share (SEK) (ttm) 5.4130
Est. EPS (SEK) (12/2015) 8.1100
Est. PEG Ratio -
Market Cap (M SEK) 5,017.21
Shares Outstanding (M) 16.53
30 Day Average Volume 34,990
Price/Book (mrq) 15.3593
Price/Sale (ttm) 11.6131
Dividend Indicated Gross Yield 1.19%
Cash Dividend (SEK) 3.4600
Dividend Ex-Date 05/08/2015
5 Year Dividend Growth 27.23%
Next Earnings Announcement 08/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIOGB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BIOGB

BioGaia AB develops and markets health care products. The Company sells foods with healthy additives that help increase resistance against illnesses, and nutritional products with therapeutic effects for adults and children. BioGaia also sells animal feeds and performs pharmaceutical research in the United States and Sweden. Many products are sold worldwide by license.

Peter RothschildCEO/FounderMargareta HagmanExec VP:Acctg & IR
Urban StrindloevExec VP:Partner & Product DevEamonn ConnollyHead:Research
More Company Profile & Key Executives for BIOGB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil